{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:43:47Z","timestamp":1791899027693,"version":"4.3.4"},"reference-count":93,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2016.00974","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T13:20:29Z","timestamp":1466688029000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":268,"title":["Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment"],"prefix":"10.3389","volume":"7","author":[{"given":"Sabine","family":"Pereyre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Goret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"B\u00e9b\u00e9ar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,6,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.7883\/yoken.65.535","article-title":"In vitro activities of 11 antimicrobial agents against macrolide-resistant Mycoplasma pneumoniae isolates from pediatric patients: results from a multicenter surveillance study","volume":"65","author":"Akaike","year":"2012","journal-title":"Jpn. J. Infect. Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/j.1574-6976.2008.00129.x","article-title":"Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections","volume":"32","author":"Atkinson","year":"2008","journal-title":"FEMS Microbiol. Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e1605","DOI":"10.1542\/peds.2010-2624","article-title":"Stevens-Johnson syndrome in a boy with macrolide-resistant Mycoplasma pneumoniae pneumonia","volume":"127","author":"Atkinson","year":"2011","journal-title":"Pediatrics"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3201\/eid\/1706.101558","article-title":"Macrolide resistance","volume":"17","author":"Averbuch","year":"2011","journal-title":"Mycoplasma pneumoniae, Israel, 2010. Emerging Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1093\/cid\/cis791","article-title":"Editorial commentary: infections due to macrolide-resistant Mycoplasma pneumoniae: now what?","volume":"55","author":"Bebear","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"B6","first-page":"535","article-title":"Antimicrobial therapy and antimicrobial resistance","author":"B\u00e9b\u00e9ar","year":"2005","journal-title":"Mycoplasmas Molecular Biology Pathogenicity and Strategies for Control"},{"key":"B7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2174\/1568005054880109","article-title":"Mechanisms of drug resistance","volume":"5","author":"B\u00e9b\u00e9ar","year":"2005","journal-title":"Mycoplasma pneumoniae. Curr. Drug Targets Infect. Disord."},{"key":"B8","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2217\/fmb.11.18","article-title":"Mycoplasma pneumoniae: susceptibility and resistance to antibiotics","volume":"6","author":"B\u00e9b\u00e9ar","year":"2011","journal-title":"Future Microbiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1128\/JCM.01755-12","article-title":"Multilocus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical isolates from 1962 to the present: a retrospective study","volume":"50","author":"Benitez","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/cid\/ciu1162","article-title":"Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort, and response of azithromycin failures to alternative antibiotic regimens","volume":"60","author":"Bissessor","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"30078","DOI":"10.2807\/1560-7917.ES.2015.20.48.30078","article-title":"Detection of macrolide resistant Mycoplasma pneumoniae in England, September 2014 to September 2015","volume":"20","author":"Brown","year":"2015","journal-title":"Euro. Surveill."},{"key":"B13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1086\/653535","article-title":"High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China","volume":"51","author":"Cao","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1128\/JCM.02840-12","article-title":"Clinical relevance of Mycoplasma pneumoniae macrolide resistance in children","volume":"51","author":"Cardinale","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1183\/09031936.00172510","article-title":"Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia","volume":"37","author":"Cardinale","year":"2011","journal-title":"Eur. Respir. J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.nmni.2015.05.005","article-title":"International Mycoplasma pneumoniae typing study: interpretation of M. pneumoniae multilocus variable-number tandem-repeat analysis","volume":"7","author":"Chalker","year":"2015","journal-title":"New Microb. New Infect."},{"key":"B17","doi-asserted-by":"crossref","first-page":"20081","DOI":"10.2807\/ese.17.06.20081-en","article-title":"Increased detection of Mycoplasma pneumoniae infection in children in England and Wales, October 2011 to January 2012","volume":"17","author":"Chalker","year":"2012","journal-title":"Euro. Surveill."},{"key":"B18","doi-asserted-by":"crossref","first-page":"19865","DOI":"10.2807\/ese.16.19.19865-en","article-title":"Increased incidence of Mycoplasma pneumoniae infection in England and Wales in 2010: multilocus variable number tandem repeat analysis typing and macrolide susceptibility","volume":"16","author":"Chalker","year":"2011","journal-title":"Euro Surveill."},{"key":"B19","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/jac\/dkr003","article-title":"Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children","volume":"66","author":"Chironna","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"B20","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1177\/0956462413502008","article-title":"Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance","volume":"24","author":"Couldwell","year":"2013","journal-title":"Int. J. STD AIDS."},{"key":"B21","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1046\/j.1469-0691.2002.00392.x","article-title":"In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe","volume":"8","author":"Critchley","year":"2002","journal-title":"Clin. Microbiol. Infect."},{"key":"B22","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1128\/JCM.01935-08","article-title":"Development of multiple-locus variable-number tandem-repeat analysis for molecular typing of Mycoplasma pneumoniae","volume":"47","author":"D\u00e9grange","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1093\/jac\/dkn118","article-title":"Reduced susceptibility to tetracyclines is associated in vitro with the presence of 16S rRNA mutations in Mycoplasma hominis and Mycoplasma pneumoniae","volume":"61","author":"Degrange","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"B24","doi-asserted-by":"publisher","first-page":"ofv106","DOI":"10.1093\/ofid\/ofv106","article-title":"Molecular detection and characterization of Mycoplasma pneumoniae among patients hospitalized with community-acquired pneumonia in the United States","volume":"2","author":"Diaz","year":"2015a","journal-title":"Open Forum Infect. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1128\/JCM.02597-14","article-title":"Investigations of Mycoplasma pneumoniae infections in the United States: trends in molecular typing and macrolide resistance from 2006 to 2013","volume":"53","author":"Diaz","year":"2015b","journal-title":"J. Clin. Microbiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1128\/AAC.00706-13","article-title":"Low rate of macrolide resistance in Mycoplasma pneumoniae strains in Germany between 2009 and 2012","volume":"57","author":"Dumke","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B27","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3201\/eid2103.140927","article-title":"Mycoplasma pneumoniae and Chlamydia spp. infection in community-acquired pneumonia, Germany, 2011-2012","volume":"21","author":"Dumke","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ijid.2014.07.014","article-title":"Molecular characterization of macrolide resistance of a Mycoplasma pneumoniae strain that developed during therapy of a patient with pneumonia","volume":"29","author":"Dumke","year":"2014","journal-title":"Int. J. Infect. Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/j.1469-0691.2009.02968.x","article-title":"Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany","volume":"16","author":"Dumke","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.3201\/eid1909.121466","article-title":"Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011","volume":"19","author":"Eshaghi","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ijantimicag.2011.01.008","article-title":"Levofloxacin for the treatment of Mycoplasma pneumoniae-associated meningoencephalitis in childhood","volume":"37","author":"Esposito","year":"2011","journal-title":"Int. J. Antimicrob. Agents."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1099\/jmm.0.066191-0","article-title":"Clinical outcomes and macrolide resistance in Mycoplasma pneumoniae infection in Scotland, UK","volume":"62","author":"Ferguson","year":"2013","journal-title":"J. Med. Microbiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s00467-013-2541-5","article-title":"Hemolytic uremic syndrome complicating Mycoplasma pneumoniae infection","volume":"28","author":"Godron","year":"2013","journal-title":"Pediatr. Nephrol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1128\/AAC.49.3.1190-1193.2005","article-title":"In vitro development of resistance to six and four fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, respectively","volume":"49","author":"Gruson","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1128\/JCM.01248-12","article-title":"Multilocus variable-number tandem-repeat analysis-confirmed emergence of a macrolide resistance-associated mutation in Mycoplasma pneumoniae during macrolide therapy for interstitial pneumonia in an immunocompromised child","volume":"50","author":"Hantz","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2011-200598","article-title":"British Thoracic Society guidelines for the management of community acquired pneumonia in children: update","volume":"66","author":"Harris","year":"2011","journal-title":"Thorax"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3560","DOI":"10.1128\/JCM.01983-15","article-title":"Emergence of macrolide-resistant Mycoplasma pneumoniae in Hong Kong is linked to increasing macrolide resistance in multilocus variable-number tandem-repeat analysis type 4-5-7-2","volume":"53","author":"Ho","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3201\/eid1908.121455","article-title":"Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011","volume":"19","author":"Hong","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"186","DOI":"10.7883\/yoken.JJID.2015.054","article-title":"Regional differences in prevalence of macrolide-resistant Mycoplasma pneumoniae in Hokkaido, Japan","volume":"69","author":"Ishiguro","year":"2015","journal-title":"Jpn. J. Infect. Dis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.mimet.2014.04.009","article-title":"Single-nucleotide polymorphism PCR for the detection of Mycoplasma pneumoniae and determination of macrolide resistance in respiratory samples","volume":"102","author":"Ji","year":"2014","journal-title":"J. Microbiol. Methods."},{"key":"B41","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.1128\/AAC.00663-13","article-title":"Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients","volume":"57","author":"Kawai","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B42","doi-asserted-by":"publisher","first-page":"30018","DOI":"10.2807\/1560-7917.ES.2015.20.37.30018","article-title":"Prevalence, genotyping and macrolide resistance of Mycoplasma pneumoniae among isolates of patients with respiratory tract infections, Central Slovenia, 2006 to 2014","volume":"20","author":"Kogoj","year":"2015","journal-title":"Euro Surveill."},{"key":"B43","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1128\/JCM.00400-10","article-title":"Nested PCR-linked capillary electrophoresis and single-strand conformation polymorphisms for detection of macrolide-resistant Mycoplasma pneumoniae in Beijing, China","volume":"48","author":"Lin","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.diagmicrobio.2010.03.004","article-title":"Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China","volume":"67","author":"Liu","year":"2010","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1128\/JCM.00678-12","article-title":"Multiclonal origin of macrolide-resistant Mycoplasma pneumoniae isolates as determined by multilocus variable-number tandem-repeat analysis","volume":"50","author":"Liu","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s10156-009-0715-7","article-title":"A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients","volume":"15","author":"Matsubara","year":"2009","journal-title":"J. Infect. Chemother."},{"key":"B48","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1186\/1471-2334-13-591","article-title":"Gene and cytokine profile analysis of macrolide-resistant Mycoplasma pneumoniae infection in Fukuoka, Japan","volume":"13","author":"Matsuda","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.1128\/AAC.48.12.4624-4630.2004","article-title":"Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan","volume":"48","author":"Matsuoka","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"B50","doi-asserted-by":"publisher","first-page":"w14041","DOI":"10.4414\/smw.2014.14041","article-title":"Survey of macrolide-resistant Mycoplasma pneumoniae in children with community-acquired pneumonia in Switzerland","volume":"144","author":"Meyer Sauteur","year":"2014","journal-title":"Swiss Med. Wkly."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1097\/INF.0b013e318266abff","article-title":"Neuroinvasive Mycoplasma pneumoniae infection without intrathecal antibody response","volume":"31","author":"Meyer Sauteur","year":"2012","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B52","doi-asserted-by":"publisher","first-page":"5181","DOI":"10.1128\/AAC.00737-13","article-title":"Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility, and therapeutic efficacy","volume":"57","author":"Miyashita","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B53","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1128\/AAC.00779-07","article-title":"Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia","volume":"52","author":"Morozumi","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"B54","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s10156-009-0021-4","article-title":"Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia","volume":"16","author":"Morozumi","year":"2010","journal-title":"J. Infect. Chemother."},{"key":"B55","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S0022-3476(70)80485-1","article-title":"Resistance of Mycoplasma pneumoniae to erythromycin and other antibiotics","volume":"76","author":"Niitu","year":"1970","journal-title":"J. Pediatr."},{"key":"B56","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1471-2180-8-93","article-title":"Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection","volume":"8","author":"Nilsson","year":"2008","journal-title":"BMC Microbiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1093\/cid\/cis784","article-title":"Rapid effectiveness of minocycline or doxyxycline against macrolide-resistant Mycoplasma pneumoniae infection in a outbreak among japanese children","volume":"55","author":"Okada","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e38585","DOI":"10.1371\/journal.pone.0038585","article-title":"The spread of Mycoplasma pneumoniae is polyclonal in both an endemic setting in France and in an epidemic setting in Israel","volume":"7","author":"Pereyre","year":"2012","journal-title":"PLoS ONE"},{"key":"B59","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.1128\/JCM.01345-07","article-title":"First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years","volume":"45","author":"Pereyre","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1128\/AAC.48.2.460-465.2004","volume":"48","author":"Pereyre","year":"2004a","journal-title":"In vitro"},{"key":"B61","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1128\/AAC.48.8.3165-3168.2004","article-title":"In vitro activities of the newer quinolones garenoxacin, gatifloxacin, and gemifloxacin against human mycoplasmas","volume":"48","author":"Pereyre","year":"2004b","journal-title":"Antimicrob. Agents Chemother."},{"key":"B62","doi-asserted-by":"publisher","first-page":"E212","DOI":"10.1111\/1469-0691.12107","article-title":"The increased incidence of Mycoplasma pneumoniae in France in 2011 was polyclonal, mainly involving M. pneumoniae type 1 strains","volume":"19","author":"Pereyre","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"B63","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/jac\/dkp160","article-title":"Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis","volume":"64","author":"Peuchant","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1128\/AAC.01666-10","article-title":"In vitro and in vivo profiles of ACH-702, an isothiazoloquinolone, against bacterial pathogens","volume":"55","author":"Pucci","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1093\/nar\/30.9.2031","article-title":"Genomic repeats, genome plasticity and the dynamics of Mycoplasma evolution","volume":"30","author":"Rocha","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1093\/jac\/dks001","article-title":"Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs)","volume":"67","author":"Sader","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"B67","first-page":"173","article-title":"Clinical efficacy of tosufloxacin in children with pneumonia due to Mycoplasma pneumoniae","volume":"65","author":"Sakata","year":"2012","journal-title":"Jpn. J. Antibiot."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3201\/eid1410.080157","article-title":"Confirmed Mycoplasma pneumoniae endocarditis","volume":"14","author":"Scapini","year":"2008","journal-title":"Emerging Infect. Dis."},{"key":"B69","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.mimet.2010.06.004","article-title":"Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae by pyrosequencing","volume":"82","author":"Spuesens","year":"2010","journal-title":"J. Microbiol. Methods."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1128\/JCM.00400-12","article-title":"Macrolide-resistance determination and molecular typing of Mycoplasma pneumoniae in respiratory specimens collected between 1997 and 2008 in The Netherlands","volume":"50","author":"Spuesens","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/jac\/18.3.359","article-title":"Resistance of Mycoplasma pneumoniae to macrolides, lincomycin and streptogramin B","volume":"18","author":"Stopler","year":"1986","journal-title":"J. Antimicrob. Chemother."},{"key":"B72","doi-asserted-by":"publisher","first-page":"e64607","DOI":"10.1371\/journal.pone.0064607","article-title":"Multiple-locus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical specimens and proposal for amendment of MLVA nomenclature","volume":"8","author":"Sun","year":"2013","journal-title":"PLoS ONE."},{"key":"B73","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1128\/AAC.50.2.709-712.2006","article-title":"Clinical Evaluation of Macrolide-Resistant","volume":"50","author":"Suzuki","year":"2006","journal-title":"Mycoplasma pneumoniae. Antimicrob. Agents Chemother."},{"key":"B74","doi-asserted-by":"crossref","first-page":"20073","DOI":"10.2807\/ese.17.05.20073-en","article-title":"Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011","volume":"17","author":"Uldum","year":"2012","journal-title":"Euro. Surveill."},{"key":"B75","volume-title":"Methods for Antimicrobial Susceptibility Testing for Human Mycoplasmas : Approved Guideline.","author":"Waites","year":"2011"},{"key":"B76","article-title":"Chemotherapy of Mycoplasma and Ureaplasma infections","volume-title":"Encyclopedia of Pharmaceutical Microbiology","author":"Waites","year":"2013"},{"key":"B77","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1128\/AAC.00090-09","article-title":"Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101","volume":"53","author":"Waites","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"B78","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1128\/AAC.04945-14","article-title":"In vitro antibacterial activity of AZD0914 against human Mycoplasmas and Ureaplasmas","volume":"59","author":"Waites","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B79","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1128\/AAC.00582-08","article-title":"Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis","volume":"52","author":"Wolff","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"B80","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/j.1469-0691.2011.03672.x","article-title":"Guidelines for the management of adult lower respiratory tract infections\u2013full version.","volume":"17","author":"Woodhead","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"B81","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/ppul.22706","article-title":"Epidemiology and clinical manifestations of children with macrolide-resistant Mycoplasma pneumoniae pneumonia in Taiwan","volume":"48","author":"Wu","year":"2013","journal-title":"Pediatr. Pulmonol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1128\/AAC.01563-08","article-title":"Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China","volume":"53","author":"Xin","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1128\/JCM.03366-13","article-title":"Molecular characterizations of PCR-positive Mycoplasma pneumoniae specimens collected from Australia and China","volume":"52","author":"Xue","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/INF.0b013e318247f3e0","article-title":"Rising rates of macrolide-resistant Mycoplasma pneumoniae in the central United States","volume":"31","author":"Yamada","year":"2012","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B85","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1128\/AAC.01561-06","article-title":"Activity of garenoxacin against macrolide-susceptible and -resistant Mycoplasma pneumoniae","volume":"51","author":"Yamazaki","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"B86","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1128\/JCM.02468-15","article-title":"Comparison of molecular characteristics of Mycoplasma pneumoniae collected from, U.S. and China","volume":"53","author":"Yan","year":"2015","journal-title":"J. Clin. Microbiol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"4168","DOI":"10.1128\/JCM.02178-14","article-title":"A single-tube multiple-locus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical specimens by use of multiplex PCR-capillary electrophoresis","volume":"52","author":"Yan","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1128\/JCM.00105-11","article-title":"Sequence analysis of the P1 adhesin gene of Mycoplasma pneumoniae in clinical isolates collected in Beijing in 2008 to 2009","volume":"49","author":"Zhao","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1128\/JCM.02567-12","article-title":"Multiple-locus variable-number tandem-repeat analysis of 201 Mycoplasma pneumoniae isolates from Beijing, China, from 2008 to 2011","volume":"51","author":"Zhao","year":"2013a","journal-title":"J. Clin. Microbiol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1128\/AAC.02060-12","article-title":"Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012","volume":"57","author":"Zhao","year":"2013b","journal-title":"Antimicrob. Agents Chemother."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.3201\/eid2108.150273","article-title":"Macrolide-resistant Mycoplasma pneumoniae, United States","volume":"21","author":"Zheng","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1128\/AAC.01806-13","article-title":"More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia","volume":"58","author":"Zhou","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1128\/AAC.04308-14","article-title":"Macrolide-resistant Mycoplasma pneumoniae in adults in Zhejiang, China","volume":"59","author":"Zhou","year":"2015","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T22:56:11Z","timestamp":1656716171000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fmicb.2016.00974\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,22]]},"references-count":93,"URL":"https:\/\/doi.org\/10.3389\/fmicb.2016.00974","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,22]]}}}